Latest Production News

Parkway Corporate Limited reports a robust December quarter with a 420% revenue increase and key milestones in brine processing technology, positioning itself as a pivotal player in Queensland's CSG industry.

International Graphite Limited has locked in a $2 million government grant to fund critical feasibility studies for its Western Australian battery anode materials project, reinforcing its mine-to-market strategy.

Rhythm Biosciences reported a strong December quarter, securing a $3.2 million R&D tax incentive and completing a strategic acquisition of Genetype assets, positioning the company for commercial expansion in cancer diagnostics.

Golden Mile Resources has identified a significant new gold target, the Aurora Prospect, within its Pearl Copper Project in Arizona, with rock chip samples returning up to 10.8 g/t gold. The company is advancing towards a maiden drilling campaign at its Odyssey and Ford Prospects, signaling a pivotal exploration phase.

Golden Horse Minerals has swiftly completed its inaugural drilling campaign at Hakes Find shortly after its ASX debut, setting the stage for an active exploration year in 2025.

Felix Gold Limited reports outstanding trenching results at its Treasure Creek Project in Alaska, revealing high-grade antimony and gold mineralization that bolsters prospects for near-term production amid critical U.S. supply chain needs.

Great Divide Mining has completed due diligence on the Adelong Gold Project, clearing the way to acquire a 15% stake and take operational control. The company aims to swiftly restart production at the historic mine.

BPH Global has completed its acquisition of Indonesian seaweed assets, establishing a wholly owned subsidiary and launching joint operations aimed at expanding seaweed cultivation and bio-stimulant product development across Asia.

EZZ Life Science Holdings delivered a robust Q2 FY25 with a 16.6% increase in customer receipts and a 308% jump in operating cash flows, while gearing up for US market entry and expanding its global footprint.

Imricor Medical Systems reports strong Q4 CY24 progress with successful FDA review, CE Mark submissions, and an 840% jump in consumables revenue, positioning the company for expanded global market penetration.

Orpheus Uranium Limited reports a productive December quarter marked by a successful $1.66 million capital raise, completion of a major gravity survey at Mount Douglas, and ongoing progress toward regulatory approvals for advanced uranium exploration.

The Calmer Co. International Limited has reported a remarkable surge in sales and cash receipts for the first half of FY25, exceeding the entire FY24 sales. Alongside a strategic CEO transition and factory upgrade, the company is sharpening its focus on profitable growth and cost control.